Department of Medicine
Faculty Profiles by Division

Division of Infectious Diseases

Faculty Profiles
[Return To Index page]
photo Ken S. Ho, MD, MPH

Infectious Diseases

Associate Professor of Medicine

Medical Director, Pitt Men's Study, Multicenter AIDS Cohort Study

Medical Director, Project Silk

Pharmacovigilance Safety Officer

Email: hok2@upmc.edu

Phone: 412-383-1675
Contact
Office: Keystone Bldg.
Keystone Bldg. 5th Floor
Pittsburgh, PA 15213
 
Phone: 412-383-1675
Fax: 412-383-2900
E-mail: hok2@upmc.edu
Administrative Assistant:
Ari Blackford-Rupp
Address: Keystone Building
3520 Fifth Ave., 5th Fl
Pittsburgh, PA 15213
Email: akb121@pitt.edu
Phone: 412-383-1675
Fax: 412-383-2900
Education and Training
Education
B.A., Plant Biology, Cornell University, Ithaca, New York, 1998
Doctor of Medicine, University of Maryland, Baltimore, Maryland, 2004
Master of Public Health, Epidemiology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland, 2003
Training
Resident, Internal Medicine, University of Pittsburgh, School of Medicine, 2007
Research Interest
Dr. Ho's primary research focuses on biomedical strategies for HIV prevention, and in particular, HIV pre-exposure prophylaxis (PrEP) and microbicide development. He conducts multiple clinical trials of PrEP and microbicides at the University of Pittsburgh Clinical Trial Unit. He was the investigator of record for the Next-PrEP Study (HPTN-069), a safety and tolerability study of maraviroc based regimens for PrEP. He is the protocol chair for MTN-033: An Open Label Randomized Phase 1 Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults. He is also the investigator of record of several other microbicide studies such as DREAM-01 (evaluation of a tenofovir enema) and MTN-026 (Dapivirine gel). Dr. Ho is the Medical Director of the Pitt Mens Study, the Pittsburgh branch of the Multicenter AIDS Cohort Study. He conducts studies of periodic PrEP use and is the principal investigator of the EpiPrEP Pilot Study, which is looking at Intermittent PrEP for HIV prevention among gay, bisexual and other men who have sex with men (msm).
Clinical Interest
Dr. Ho's clinical interests involve HIV PrEP, HIV clinical care, and general infectious diseases. He established the PrEP prophylaxis clinic at the University of Pittsburgh Medical Center in early 2013. He is also an HIV clinician and rounds on the general infectious diseases service.
Publications
For my complete bibliography, Click Here.
Sponsored Research/Activities
Title: CoVPN 5002 Seroprevalence Study
Role: Principal Investigator
Funding Agency: Family Health International
Grant Number: AI068619
Start Year: 2020
End Year: 2021
Title: A Test of Scalable Behavioral Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves
Role: Principal Investigator
Funding Agency: Allegheny-Singer Research Institute / Gilead Sciences, Inc
Grant Number: CRA
Start Year: 2019
End Year: 2021
Title: Pitt-Ohio State - Georgetown Clinical Trials Unit
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: UM1 AI069494
Start Year: 2013
End Year: 2020
Title: University of Pittsburgh MACS-WIHS CCS
Role: Director
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: U01 HL146208
Start Year: 2019
End Year: 2026

Division Websites

Cardiology

Endocrinology and Metabolism

Gastroenterology, Hepatology and Nutrition

General Internal Medicine

Geriatric Medicine
Hematology/Oncology

Infectious Diseases

Pulmonary, Allergy and Critical Care Medicine

Renal-Electrolyte

Rheumatology and Clinical Immunology

Contact

Department of Medicine
1218 Scaife Hall
3550 Terrace Street
Pittsburgh, PA 15261
Email:  chairoff@pitt.edu
Phone:  412-648-9636
Copyright © 2018 Department of Medicine / University of Pittsburgh School of Medicine
Site maintained by Medicine Technology Services MTS@PITT.EDU